skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 89  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study
Material Type:
Article
Add to My Research

Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study

The Lancet (British edition), 2017-11, Vol.17 (11), p.1200-1208 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 1, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1473-3099 ;ISSN: 0140-6736 ;EISSN: 1474-4457 ;EISSN: 1474-547X ;DOI: 10.1016/S1473-3099(17)30444-9 ;PMID: 28838639

Full text available

2
Organ procurement and transplantation during the COVID-19 pandemic
Material Type:
Article
Add to My Research

Organ procurement and transplantation during the COVID-19 pandemic

The Lancet, 2020-05, Vol.395 (10237), p.e95-e96 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31040-0 ;PMID: 32407668

Digital Resources/Online E-Resources

3
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Material Type:
Article
Add to My Research

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

The Lancet (British edition), 2019-04, Vol.393 (10179), p.1453-1464 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32111-1 ;PMID: 30765123

Full text available

4
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
Material Type:
Article
Add to My Research

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

The Lancet (British edition), 2020-07, Vol.396 (10244), p.121-128 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30748-0 ;PMID: 32446323

Full text available

5
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
Material Type:
Article
Add to My Research

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

The Lancet (British edition), 2009-04, Vol.373 (9672), p.1352-1363 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Apr 18-Apr 24, 2009 ;Distributed under a Creative Commons Attribution 4.0 International License ;2009 Elsevier Ltd. All rights reserved. 2009 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60612-7 ;PMID: 19361855 ;CODEN: LANCAO

Full text available

6
Heart failure drug treatment
Material Type:
Article
Add to My Research

Heart failure drug treatment

The Lancet (British edition), 2019-03, Vol.393 (10175), p.1034-1044 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31808-7 ;PMID: 30860029

Full text available

7
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial
Material Type:
Article
Add to My Research

Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial

The Lancet (British edition), 2018-07, Vol.392 (10141), p.31-40 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 7, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31080-8 ;PMID: 29910040

Full text available

8
An assessment of interactions between global health initiatives and country health systems
Material Type:
Article
Add to My Research

An assessment of interactions between global health initiatives and country health systems

The Lancet (British edition), 2009-06, Vol.373 (9681), p.2137-2169 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Jun 20-Jun 26, 2009 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60919-3 ;PMID: 19541040 ;CODEN: LANCAO

Full text available

9
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Material Type:
Article
Add to My Research

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

The Lancet (British edition), 2022-12, Vol.400 (10367), p.1927-1937 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02034-7 ;PMID: 36356632

Full text available

10
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
Material Type:
Article
Add to My Research

Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series

The Lancet (British edition), 2022-12, Vol.400 (10367), p.1953-1965 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2022 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02187-0 ;PMID: 36403584

Full text available

11
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
Material Type:
Article
Add to My Research

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

The Lancet (British edition), 2021-01, Vol.397 (10272), p.398-408 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32657-X ;PMID: 33516338

Full text available

12
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Material Type:
Article
Add to My Research

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

The Lancet (British edition), 2020-06, Vol.395 (10242), p.1988-1997 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution - NonCommercial - NoDerivatives ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30689-9 ;PMID: 32593336

Full text available

13
The evolving landscape of pulmonary arterial hypertension clinical trials
Material Type:
Article
Add to My Research

The evolving landscape of pulmonary arterial hypertension clinical trials

The Lancet (British edition), 2022-11, Vol.400 (10366), p.1884-1898 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01601-4 ;PMID: 36436527

Full text available

14
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Material Type:
Article
Add to My Research

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

The Lancet (British edition), 2021-09, Vol.398 (10304), p.957-980 [Peer Reviewed Journal]

2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;info:eu-repo/semantics/openAccess ;Attribution ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01330-1 ;PMID: 34450083

Full text available

15
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent
Material Type:
Article
Add to My Research

After 2 years of the COVID-19 pandemic, translating One Health into action is urgent

The Lancet (British edition), 2023-03, Vol.401 (10378), p.789-794 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01840-2 ;PMID: 36302392

Full text available

16
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
Material Type:
Article
Add to My Research

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

The Lancet (British edition), 2022-11, Vol.400 (10363), p.1607-1617 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2022 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01846-3 ;PMID: 36328042

Full text available

17
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment
Material Type:
Article
Add to My Research

Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment

The Lancet (British edition), 2021-08, Vol.398 (10302), p.772-785 [Peer Reviewed Journal]

2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01112-0 ;PMID: 34454675

Full text available

18
Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme
Material Type:
Article
Add to My Research

Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme

The Lancet (British edition), 2018-05, Vol.391 (10133), p.1916-1926 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Distributed under a Creative Commons Attribution 4.0 International License ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)30792-X ;PMID: 29703425

Full text available

19
An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2
Material Type:
Article
Add to My Research

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2

The Lancet (British edition), 2021-10, Vol.398 (10309), p.1402-1404 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;Copyright ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02019-5 ;PMID: 34543608

Full text available

20
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

The Lancet (British edition), 2021-02, Vol.22 (2), p.198-211 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;ISSN: 0140-6736 ;EISSN: 1474-5488 ;EISSN: 1474-547X ;DOI: 10.1016/S1470-2045(20)30641-0 ;PMID: 33476593

Full text available

Results 1 - 20 of 89  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait